ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
First US Service Members Treated with the Only FDA-Approved Cross-Linking Procedure in the U.S.
americanpharmaceuticalreview
January 16, 2017Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has begun selling Photrexa Viscous? (riboflavin 5-‘phosphate in 20% dextran ophthalmic solution), Photrexa? (riboflavin 5’-phosphate ophthalmic solution) and the KXL? System to key mil
Pharma Sources Insight January 2025
